CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages

Biochemical and Biophysical Research Communications

Volumn 458, Issue 4, 2015, Pages 890-895

  Li, Jun ^a,b   Zhang, Peng ^a,b   Li, Tingting ^a,b   Liu, Yawei ^a,b   Zhu, Qing ^a,b   Chen, Tongshuai ^a,b   Liu, Tianjiao ^a,b   Huang, Chengmin ^a,b   Zhang, Jianning ^a,b   Zhang, Yun ^a,b   Guo, Yuan ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Anti inflammation; Atherosclerosis; CTRP9; Plaque stabilization

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; COMPLEMENT COMPONENT C1Q; CYTOKINE; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED PROTEIN 9; UNCLASSIFIED DRUG; ADIPONECTIN; CTRP9 PROTEIN, MOUSE; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME STABILITY; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE CELL; ADMINISTRATION AND DOSAGE; ANIMAL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL LINE; GENE VECTOR; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; UPREGULATION;

ADIPONECTIN; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERIES; CELL LINE; CYTOKINES; GENETIC VECTORS; GLYCOPROTEINS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; TRANSFECTION; UP-REGULATION;

EID: 84925533865     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.054     Document Type: Article

References (31)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, R.H. Mackey, D.J. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler 3rd, C.S. Moy, M.E. Mussolino, R.W. Neumar, G. Nichol, D.K. Pandey, N.P. Paynter, M.J. Reeves, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. J. Narula, P. Garg, S. Achenbach, S. Motoyama, R. Virmani, and H.W. Strauss Arithmetic of vulnerable plaques for noninvasive imaging Nat. Clin. Pract. Cardiovasc. Med. 5 Suppl. 2 2008 S2 S10
3. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
4. P.K. Shah Biomarkers of plaque instability Curr. Cardiol. Rep. 16 2014 547
5. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
6. G.W. Wong, S.A. Krawczyk, C. Kitidis-Mitrokostas, G. Ge, E. Spooner, C. Hug, R. Gimeno, and H.F. Lodish Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin FASEB J. 23 2009 241 258
7. E.J. Folco, V.Z. Rocha, M. Lopez-Ilasaca, and P. Libby Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10 J. Biol. Chem. 284 2009 25569 25575
8. K. Ohashi, J.L. Parker, N. Ouchi, A. Higuchi, J.A. Vita, N. Gokce, A.A. Pedersen, C. Kalthoff, S. Tullin, A. Sams, R. Summer, and K. Walsh Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype J. Biol. Chem. 285 2010 6153 6160
9. N. Luo, J. Liu, B.H. Chung, Q. Yang, R.L. Klein, W.T. Garvey, and Y. Fu Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis Diabetes 59 2010 791 799
10. N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh Obesity, adiponectin and vascular inflammatory disease Curr. Opin. Lipidol. 14 2003 561 566
11. Y. Uemura, R. Shibata, K. Ohashi, T. Enomoto, T. Kambara, T. Yamamoto, Y. Ogura, D. Yuasa, Y. Joki, K. Matsuo, M. Miyabe, Y. Kataoka, T. Murohara, and N. Ouchi Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation FASEB J. 27 2013 25 33
12. Q. Zheng, Y. Yuan, W. Yi, W.B. Lau, Y. Wang, X. Wang, Y. Sun, B.L. Lopez, T.A. Christopher, J.M. Peterson, G.W. Wong, S. Yu, D. Yi, and X.L. Ma C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway Arterioscler. Thromb. Vasc. Biol. 31 2011 2616 2623
13. Y.C. Hwang, S. Woo Oh, S.W. Park, and C.Y. Park Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans Int. J. Obes. (Lond.) 2013
14. C.H. Jung, M.J. Lee, Y.M. Kang, J.E. Jang, J. Leem, Y.L. Lee, S.M. Seol, H.K. Yoon, W.J. Lee, and J.Y. Park Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes J. Clin. Endocrinol. Metab. 99 2014 E2477 E2484
15. W.S. Kang, J.S. Kwon, H.B. Kim, H.Y. Jeong, H.J. Kang, M.H. Jeong, J.G. Cho, J.C. Park, Y.S. Kim, and Y. Ahn A macrophage-specific synthetic promoter for therapeutic application of adiponectin Gene Ther. 21 2014 353 362
16. S. Takeuchi, K. Wada, Y. Uozumi, N. Otani, H. Osada, K. Nagatani, and K. Mori Adiponectin receptor 1 expression is associated with carotid plaque stability Neurol. India 61 2013 249 253
17. P. Mandal, B.T. Pratt, M. Barnes, M.R. McMullen, and L.E. Nagy Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin J. Biol. Chem. 286 2011 13460 13469
18. L. Zhong, W.Q. Chen, X.P. Ji, M. Zhang, Y.X. Zhao, G.H. Yao, P.F. Zhang, C. Zhang, and Y. Zhang Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels J. Cell. Mol. Med. 12 2008 2362 2371
19. E. Mori, K. Komori, T. Yamaoka, M. Tanii, C. Kataoka, A. Takeshita, M. Usui, K. Egashira, and K. Sugimachi Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits Circulation 105 2002 2905 2910
20. S. Yla-Herttuala, B.A. Lipton, M.E. Rosenfeld, T. Sarkioja, T. Yoshimura, E.J. Leonard, J.L. Witztum, and D. Steinberg Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions Proc. Natl. Acad. Sci. U. S. A. 88 1991 5252 5256
21. T.J. Qi, W.Q. Chen, C.L. Jiang, T.H. Yang, M.Q. Zhai, D.Q. Li, B.A. You, G.P. An, X.B. Hu, Y.G. Chen, Y. Zhang, and J.F. Li [Roles of monocyte chemoattractant protein-1, RANTES and Fractalkine on promoting vulnerability of atherosclerotic plaques] Zhonghua Xin Xue Guan Bing Za Zhi 39 2011 797 801
22. P.H. Park, H. Huang, M.R. McMullen, P. Mandal, L. Sun, and L.E. Nagy Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms J. Biol. Chem. 283 2008 26850 26858
23. A. Schmid, A. Kopp, F. Hanses, T. Karrasch, and A. Schaffler C1q/TNF-related protein-3 (CTRP-3) attenuates lipopolysaccharide (LPS)-induced systemic inflammation and adipose tissue Erk-1/-2 phosphorylation in mice in vivo Biochem. Biophys. Res. Commun. 452 2014 8 13
24. L. Tian, N. Luo, R.L. Klein, B.H. Chung, W.T. Garvey, and Y. Fu Adiponectin reduces lipid accumulation in macrophage foam cells Atherosclerosis 202 2009 152 161
25. Z.S. Galis, G.K. Sukhova, R. Kranzhofer, S. Clark, and P. Libby Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases Proc. Natl. Acad. Sci. U. S. A. 92 1995 402 406
26. P.J. Gough, I.G. Gomez, P.T. Wille, and E.W. Raines Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice J. Clin. Investig. 116 2006 59 69
27. D. Silvello, L.B. Narvaes, L.C. Albuquerque, L.F. Forgiarini, L. Meurer, N.C. Martinelli, M.E. Andrades, N. Clausell, K.G. dos Santos, and L.E. Rohde Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability Biomarkers 19 2014 49 55
28. V. Miksztowicz, N. Fernandez Machulsky, D. Lucero, E. Fassio, L. Schreier, and G. Berg Adiponectin predicts MMP-2 activity independently of obesity Eur. J. Clin. Investig. 44 2014 951 957
29. H.L. Li, H.L. Chen, H. Li, K.L. Zhang, X.Y. Chen, X.W. Wang, Q.Y. Kong, and J. Liu Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages Int. J. Mol. Med. 16 2005 41 47
30. P. Libby, Y. Okamoto, V.Z. Rocha, and E. Folco Inflammation in atherosclerosis: transition from theory to practice Circ. J. 74 2010 213 220
31. Y. Sun, W. Yi, Y. Yuan, W.B. Lau, D. Yi, X. Wang, Y. Wang, H. Su, X. Wang, E. Gao, W.J. Koch, and X.L. Ma C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation Circulation 128 2013 S113 S120